Overview
- Growth investment style that employs bottom-up, analyst-driven stock selection based on proprietary fundamental research and investment insights
- Focus on durability/sustainability of growth rather than absolute growth rates
- We believe new growth opportunities and significant alpha generation can result from correct analysis of new product opportunities
Characteristics & Performance
Composite Inception | 6/30/1999 |
| Strategy AUM | $2.1 Billion as of 3/31/25 |
| Benchmark | S&P Health Care Index |
| Holdings Range | Typically 50 – 80, +/- 15 securities |
Performance results are calculated in US dollars and reflect reinvestment of dividends and other earnings. Periods greater than one year are annualized. Please refer to the GIPS presentation, which includes fee information and criteria for composite performance creation.
Available Vehicles
*By clicking on this link you are leaving jennison.com and being redirected to a new website
Investment Team
Our Health Sciences strategy is managed by two portfolio managers. Two portfolio managers also serve as the strategy’s dedicated analysts. Together with the team’s research analysts, they comprehensively monitor the health care universe, the strategy’s sole sector focus.
- Portfolio Managers
- Research Analysts
- Client Portfolio Manager
Related Insights
-
The Spectrum of GrowthGreat growth companies are rare, prized, and often misunderstood. Investors can understand their patterns of performance to make better-informed decisions
Read More
-
Artificial Intelligence: An Accelerating RevolutionThe revolutionary impact of AI-driven change is already evident in most industries and is accelerating.
Read More
-
Celebrating 25 Years of Health CareCelebrating 25 Years of Health Care
Read More
